Table 1.
Clinical characteristics in 46 patients with cardiomyopathy
| Infiltrative cardiomyopathy (n = 11) | HCM (n = 35) | p value | |
|---|---|---|---|
| Age*, years | 68 ± 11 | 57 ± 16 | 0.015 |
| Gender: men, n (%) | 8 (73 %) | 16 (46 %) | 0.118 |
| Hs-cTnT*, ng/ml | 0.083 ± 0.057 | 0.027 ± 0.034 | <0.001 |
| BNP*, pg/ml | 349 ± 341 | 288 ± 378 | 0.322 |
| eGFR, ml/min per 1.73 m2 | 61 ± 17 | 73 ± 21 | 0.090 |
| NYHA functional class, n (%) | 0.071 | ||
| I | 2 (18 %) | 20 (57 %) | |
| II | 8 (73 %) | 14 (40 %) | |
| III | 1 (9 %) | 1 (3 %) | |
| Hx. of heart failure admission, n (%) | 5 (45 %) | 6 (17 %) | 0.100 |
| Atrial fibrillation, n (%) | 1 (9 %) | 4 (11 %) | 1.00 |
Data are shown as mean ± SD or number (percent)
A mark of * is the results of Wilcoxon rank sum test
HCM hypertrophic cardiomyopathy, Hs-cTnT High-sensitivity cardiac troponin T, BNP Brain natriuretic peptide, eGFR estimated glomerular filtration rate, NYHA New York Heart Association functional class